Live Breaking News & Updates on டக்ளஸ் முல்ஹால்

Stay updated with breaking news from டக்ளஸ் முல்ஹால். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kizoo Provides Seed Funding for Elastrin Therapeutics to Develop Groundbreaking New Technology Capable of Reversing Tissue and Organ Calcification


(1)
Elastrin is a biotechnology startup leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again. It is the latest addition to the growing portfolio of Kizoo Technology Capital, a rejuvenation biotech investor focused on reversing age-related damage on a cellular and molecular level. Elastrin s lead asset is a nanoparticle conjugated with a novel monoclonal antibody for the treatment of heart valve and vascular calcification.
Elastin fibers are critical for the homeostasis of tissues around the body, including the skin, vasculature, and pulmonary tissues. As elastin fibers become damaged over time, arterial walls weaken, and the body s physiological response results in aortic wall stiffening, aneurysms, and hypertension, said Prof. Naren Vyavahare, Chief Scientific Officer at Elastrin Therapeutics. ....

Douglas Mulhall , Wordstatt Gmb , Patrick Burgermeister , Naren Vyavahare , Matthias Breugelmans , Dagmar Metzger , Frank Schueler , Charles Rice , Revel Pharmaceuticals , Kizoo Technology Capital , Clemson University , Healthy Group , Partner At Kizoo Technology Capital , Elastrin Therapeutics Inc , Chief Scientific Officer , Managing Director , Kizoo Technology , South Carolina Based , Forever Healthy Group , Undoing Aging , Ground Breaking , டக்ளஸ் முல்ஹால் , டாக்மார் மெதஜ்கேர் , வெளிப்படையான ஸ்கூலர் , சார்லஸ் அரிசி , மகிழ்ச்சி மருந்துகள் ,